Lantern Pharma Inc. (LTRN)
NASDAQ: LTRN
· Real-Time Price · USD
4.20
-0.09 (-2.10%)
At close: Sep 04, 2025, 3:59 PM
4.11
-2.14%
Pre-market: Sep 05, 2025, 09:10 AM EDT
-2.10% (1D)
| Bid | 4.09 |
| Market Cap | 45.36M |
| Revenue (ttm) | 100.65K |
| Net Income (ttm) | -19.25M |
| EPS (ttm) | -1.78 |
| PE Ratio (ttm) | -2.36 |
| Forward PE | -2.18 |
| Analyst | Buy |
| Ask | 4.46 |
| Volume | 85,869 |
| Avg. Volume (20D) | 251,569 |
| Open | 4.34 |
| Previous Close | 4.29 |
| Day's Range | 4.07 - 4.44 |
| 52-Week Range | 2.55 - 6.12 |
| Beta | 1.59 |
About LTRN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LTRN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LTRN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-3.99%
Lantern Pharma shares are trading lower. The compa...
Unlock content with
Pro Subscription
1 month ago
+10.72%
Lantern Pharma shares are trading higher after the company announced early enrollment in Japan for lung cancer.
